0

BOSULIF از شرکت PF PRISM CV

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

BOSULIF از شرکت PF PRISM CV

New Drug Application (NDA): 203341

Company: PF PRISM CV

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BOSULIF BOSUTINIB MONOHYDRATE EQ 100MG BASE TABLET;ORAL Prescription

None

Yes Yes
BOSULIF BOSUTINIB MONOHYDRATE EQ 500MG BASE TABLET;ORAL Prescription

None

Yes No
BOSULIF BOSUTINIB MONOHYDRATE EQ 400MG BASE TABLET;ORAL Prescription

None

Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/04/2012 ORIG-1 Approval

Type 1 – New Molecular Entity

STANDARD; Orphan

Label (PDF)

Letter (PDF)

Review

Summary Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/203341Orig1s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203341_bosulif_toc.cfm
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/022090s000_SumR.pdf

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
05/14/2021 SUPPL-20 Efficacy-Accelerated Approval

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203341s020lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/203341Orig1s020ltr.pdf

06/17/2020 SUPPL-18 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203341s018lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/203341Orig1s018ltr.pdf

10/09/2019 SUPPL-17 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203341s017lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/203341Orig1s017ltr.pdf

08/14/2019 SUPPL-16 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203341s016lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/203341Orig1s016ltr.pdf

10/18/2018 SUPPL-15 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/203341s015lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/203341Orig1s015ltr.pdf

05/01/2018 SUPPL-13 Labeling-Container/Carton Labels

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/203341Orig1s013ltr.pdf

12/19/2017 SUPPL-9 Efficacy-New Indication

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203341s009lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/203341Orig1s009ltr.pdf

04/13/2017 SUPPL-8 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/20334s007s008lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/203341Orig1s007s008ltr.pdf

04/13/2017 SUPPL-7 Efficacy-Labeling Change With Clinical Data

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/20334s007s008lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/203341Orig1s007s008ltr.pdf

11/17/2016 SUPPL-6 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203341s006lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/203341Orig1s006ltr.pdf

04/04/2016 SUPPL-5 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203341s005lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/203341Orig1s005ltr.pdf

10/08/2015 SUPPL-4 Labeling-Container/Carton Labels

Label is not available on this site.

09/22/2015 SUPPL-3 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203341s003lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/203341Orig1s003ltr.pdf

11/25/2014 SUPPL-2 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203341s002lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203341Orig1s002ltr.pdf

09/30/2013 SUPPL-1 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203341s001lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/203341Orig1s001ltr.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
05/14/2021 SUPPL-20

Efficacy-Accelerated Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203341s020lbl.pdf
06/17/2020 SUPPL-18

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203341s018lbl.pdf
10/09/2019 SUPPL-17

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203341s017lbl.pdf
08/14/2019 SUPPL-16

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203341s016lbl.pdf
10/18/2018 SUPPL-15

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/203341s015lbl.pdf
12/19/2017 SUPPL-9

Efficacy-New Indication

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203341s009lbl.pdf
04/13/2017 SUPPL-8

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/20334s007s008lbl.pdf
04/13/2017 SUPPL-7

Efficacy-Labeling Change With Clinical Data

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/20334s007s008lbl.pdf
11/17/2016 SUPPL-6

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203341s006lbl.pdf
04/04/2016 SUPPL-5

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203341s005lbl.pdf
09/22/2015 SUPPL-3

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203341s003lbl.pdf
11/25/2014 SUPPL-2

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203341s002lbl.pdf
09/30/2013 SUPPL-1

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203341s001lbl.pdf
09/04/2012 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf
حتما بخوانید : ACETYLCYSTEINE از شرکت HOSPIRA
برچسب‌ها:

نظرات کاربران